Drug Dmd

Emflaza

Payments companies reported to CMS as associated with Emflaza. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$20Kassociated payments (2023-2025)
177clinicians with associated payments
1company reporting

By year

2023 $16K
2024 $3,722
2025 $399

Payments reported as associated with Emflaza, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Clinical Genetics (M.D.) $6,556
Neurology With Special Qualifications In Child Neurology $4,873
Pediatrics $2,017
Neurology (Psychiatry & Neurology) $1,056
Family $887
Pediatrics (Nurse Practitioner) $647

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Emflaza

These are the largest totals companies reported as associated with Emflaza. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Joseph Ray Galveston, TX Clinical Genetics (M.D.) $5,859.28
Michelle Figueroa Detroit, MI Neurology With Special Qualifications In Child Neurology $568.75
Edwardo Ramos Cortes San Juan, PR Physical Medicine & Rehabilitation $288.89
Cesar Santos Madera, CA Neurology With Special Qualifications In Child Neurology $199.28
Milagros Silva-Colon Madera, CA Neurology With Special Qualifications In Child Neurology $199.28
Raymund David Madera, CA Neurology With Special Qualifications In Child Neurology $199.28
Merveen Appu Madera, CA Neurology With Special Qualifications In Child Neurology $199.28
Wendy Nagle Madera, CA Family $199.28
Steven Ehrreich Madera, CA Pediatrics $199.28
Giancarlo Lugo Madera, CA Neurology With Special Qualifications In Child Neurology $199.28

Prescribed Emflaza?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.